Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.41
P/E—
Fwd P/E12.69
PEG1.34
52W— – —
RSI—
Target$449.1 (+19.4%)
Beta0.68
Div1.78%
Loading chart…
RSI (14)
Loading patterns…
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 42
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
3Bullish
1Bearish
0Neutral
▲ Bull Flag — Breakout after +9% pole — bullish continuation
▲ Bull Flag — Breakout after +27% pole — bullish continuation
▲ Bull Flag — Breakout after +28% pole — bullish continuation
▼ Double Top — Two peaks ~$431.61 — bearish reversal confirmed
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
62%
5/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$449.1
+19.4% upside
Low $393
—
High $492
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Leerink Partners | Market Perform | — | ↔ Maintain | 2026-07-17 |
| RBC Capital | Sector Perform | — | ↔ Maintain | 2026-07-16 |
| Wells Fargo | Overweight | — | ↔ Maintain | 2026-07-16 |
| Guggenheim | Buy | — | ↔ Maintain | 2026-07-16 |
| Barclays | Overweight | — | ↔ Maintain | 2026-07-16 |
| Baird | Neutral | — | ↔ Maintain | 2026-07-16 |
| TD Cowen | Buy | — | ↔ Maintain | 2026-07-14 |
| Truist Securities | Buy | — | ↔ Maintain | 2026-07-14 |
| Cantor Fitzgerald | Overweight | — | ↔ Maintain | 2026-07-07 |
| Bernstein | Outperform | — | ↔ Maintain | 2026-07-02 |
| Mizuho | Outperform | — | ↔ Maintain | 2026-06-08 |
| JP Morgan | Overweight | — | ↔ Maintain | 2026-06-08 |
| B of A Securities | Buy | — | ↔ Maintain | 2026-06-04 |
| Morgan Stanley | Equal-Weight | — | ↔ Maintain | 2026-06-04 |
| UBS | Buy | — | ↔ Maintain | 2026-05-22 |
| Deutsche Bank | Buy | Hold → Buy | ▲ Upgrade | 2026-05-20 |
| Evercore ISI Group | In-Line | — | ↔ Maintain | 2026-04-23 |
| Jefferies | Buy | — | ↔ Maintain | 2026-04-20 |
| Wolfe Research | Outperform | Peer Perform → Outperform | ▲ Upgrade | 2026-01-08 |
Leerink Partners
2026-07-17
Market Perform
↔ Maintain
RBC Capital
2026-07-16
Sector Perform
↔ Maintain
Wells Fargo
2026-07-16
Overweight
↔ Maintain
Guggenheim
2026-07-16
Buy
↔ Maintain
Barclays
2026-07-16
Overweight
↔ Maintain
Baird
2026-07-16
Neutral
↔ Maintain
TD Cowen
2026-07-14
Buy
↔ Maintain
Truist Securities
2026-07-14
Buy
↔ Maintain
Cantor Fitzgerald
2026-07-07
Overweight
↔ Maintain
Bernstein
2026-07-02
Outperform
↔ Maintain
Mizuho
2026-06-08
Outperform
↔ Maintain
JP Morgan
2026-06-08
Overweight
↔ Maintain
B of A Securities
2026-06-04
Buy
↔ Maintain
Morgan Stanley
2026-06-04
Equal-Weight
↔ Maintain
UBS
2026-05-22
Buy
↔ Maintain
Deutsche Bank
2026-05-20
Buy
(from Hold)
▲ Upgrade
Evercore ISI Group
2026-04-23
In-Line
↔ Maintain
Jefferies
2026-04-20
Buy
↔ Maintain
Wolfe Research
2026-01-08
Outperform
(from Peer Perform)
▲ Upgrade
Profitability
Gross Margin
25.99%TTM
Op. Margin
4.56%TTM
ROE
11.13%TTM
Rev. Growth
1.40%YoY
Free Cash Flow
4.31BTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
68.95MRQ
Current Ratio
1.52MRQ
Cash
37.51BMRQ
Total Debt
31.04BMRQ
Net Debt
—MRQ
Income
Div. Yield
1.78%TTM
Annual Rate
6.88Fwd
Payout Ratio
30.34%TTM
Dividend History
Payout Ratio (TTM): 30.34%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-06-10 | $1.7200 | 0.42% |
| 2026-03-10 | $1.7200 | 0.61% |
| 2025-12-05 | $1.7100 | 0.52% |
| 2025-09-10 | $1.7100 | 0.57% |
| 2025-06-10 | $1.7100 | 0.46% |
| 2025-03-10 | $1.7100 | 0.43% |
| 2024-12-05 | $1.6300 | 0.43% |
| 2024-09-10 | $1.6300 | 0.31% |
| 2024-06-10 | $1.6300 | 0.32% |
| 2024-03-07 | $1.6300 | 0.34% |
| 2023-12-05 | $1.4800 | 0.32% |
| 2023-09-07 | $1.4800 | 0.34% |
| 2023-06-08 | $1.4800 | 0.33% |
| 2023-03-09 | $1.4800 | 0.34% |
| 2022-12-02 | $1.2800 | 0.26% |
| 2022-09-08 | $1.2800 | 0.28% |
| 2022-06-09 | $1.2800 | 0.28% |
| 2022-03-09 | $1.2800 | 0.29% |
| 2021-12-02 | $1.1300 | 0.30% |
| 2021-09-09 | $1.1300 | 0.33% |
| 2021-06-09 | $1.1300 | 0.32% |
| 2021-03-09 | $1.1300 | 0.36% |
| 2020-12-04 | $0.9500 | 0.32% |
| 2020-09-09 | $0.9500 | 0.39% |
| 2020-06-09 | $0.9500 | 0.35% |
| 2020-03-13 | $0.9500 | 0.38% |
| 2019-12-04 | $0.8000 | 0.30% |
| 2019-09-09 | $0.8000 | 0.35% |
| 2019-06-07 | $0.8000 | 0.32% |
| 2019-03-15 | $0.8000 | 0.29% |
| 2018-12-04 | $0.7500 | 0.28% |
| 2018-09-07 | $0.7500 | 0.31% |
| 2018-06-07 | $0.7500 | 0.36% |
| 2018-03-08 | $0.7500 | 0.37% |
| 2017-12-04 | $0.7000 | 0.35% |
| 2017-09-07 | $0.7000 | 0.41% |
| 2017-06-07 | $0.6500 | 0.39% |
| 2017-03-08 | $0.6500 | 0.45% |
| 2016-12-01 | $0.6500 | 0.51% |
| 2016-09-07 | $0.6500 | 0.59% |
How ELV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 81.54B |
| Enterprise Value | 75.21B |
| Trailing P/E | 16.64 |
| Forward P/E | 12.69 |
| PEG Ratio (5yr) | 1.34 |
| Price/Sales (ttm) | 0.41 |
| Price/Book (mrq) | 1.82 |
| EV/Revenue | 0.37 |
| EV/EBITDA | 9.04 |
Share Statistics
| Avg Vol (3m) | 1.69M |
| Shares Outstanding | 216.87M |
| Float | 216.41M |
| % Held by Insiders | 0.19% |
| % Held by Institutions | 93.69% |
| Short Ratio | 3.47 |
| Short % of Float | 3.11% |
Profitability
| Gross Margin | 25.99% |
| Operating Margin (ttm) | 4.56% |
| Profit Margin | 2.47% |
| Return on Assets (ttm) | 3.83% |
| Return on Equity (ttm) | 11.13% |
Income Statement
| Revenue (ttm) | 201.11B |
| Revenue Growth (yoy) | 1.40% |
| Gross Profit (ttm) | 52.27B |
| EBITDA | 8.32B |
| Net Income (ttm) | 4.96B |
| Diluted EPS (ttm) | 22.60 |
| EPS Growth (yoy) | -13.10% |
Balance Sheet
| Total Cash (mrq) | 37.51B |
| Total Debt (mrq) | 31.04B |
| Debt / Equity (mrq) | 68.95 |
| Current Ratio (mrq) | 1.52 |
| Book Value / Share | 206.99 |
| Operating CF (ttm) | 7.46B |
| Free Cash Flow (ttm) | 4.31B |
Trading & Dividends
| Beta (5Y) | 0.68 |
| 50-Day MA | 397.84 |
| 200-Day MA | 350.82 |
| Fwd Dividend Yield | 178.00% |
| Payout Ratio | 30.34% |
Ownership Breakdown
Institutional 93.69%
Insider 0.19%
Public 6.1%
Short Interest
3.11% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in ELV in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-17 | PERU RAMIRO G | Director | Purchase at price 366.05 per share. | 1,000 | $366,050 |
| 2026-07-17 | BOUDREAUX GAIL A KOZIARA | Chief Executive Officer | Purchase at price 366.41 - 368.25 per share. | 2,725 | $1,002,230 |
| 2026-06-12 | PENCZEK RONALD W | Officer | Sale at price 403.16 per share. | 369 | $148,766 |
| 2026-06-11 | DIXON ROBERT L JR | Director | Sale at price 401.77 per share. | 151 | $60,667 |
| 2026-05-19 | PENCZEK RONALD W | Officer | Sale at price 403.13 per share. | 1,531 | $617,192 |
| 2026-05-19 | PENCZEK RONALD W | Officer | Conversion of Exercise of derivative security at price 271.27 - 311.48 per share. | 1,531 | $450,579 |
| 2026-05-13 | HAY LEWIS III | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-05-13 | JALLAL BAHIJA | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-05-13 | PERU RAMIRO G | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-05-13 | COLLIS STEVEN HOWARD | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-05-13 | DIXON ROBERT L JR | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-05-13 | DEVORE SUSAN D | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-05-13 | SCHULMAN AMY W. | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-05-13 | STRABLE-SOETHOUT DEANNA D | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-05-13 | NERI ANTONIO F | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-05-13 | SCHNEIDER RYAN M. | Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| 2026-03-12 | SCHULMAN AMY W. | Director | Sale at price 287.50 per share. | 26 | $7,475 |
| 2026-03-06 | KENDRICK CHARLES MORGAN JR | Officer | Sale at price 284.92 per share. | 3,196 | $910,604 |
| 2026-03-05 | COLLIS STEVEN HOWARD | Director | Purchase at price 289.84 per share. | 3,000 | $869,520 |
| 2026-03-02 | KENDRICK CHARLES MORGAN JR | Officer | Stock Award(Grant) at price 0.00 per share. | 6,549 | — |
| 2026-03-02 | CRAIG RYAN R | Officer | Stock Award(Grant) at price 0.00 per share. | 2,976 | — |
| 2026-03-02 | WESSLING ERIN M | Officer | Stock Award(Grant) at price 0.00 per share. | 2,976 | — |
| 2026-03-02 | LAVU RATNAKAR | Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | 11,903 | — |
| 2026-03-02 | NORWOOD FELICIA F. | Officer | Stock Award(Grant) at price 0.00 per share. | 8,816 | — |
| 2026-03-02 | KAYE MARK | Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 16,579 | — |
PERU RAMIRO G
Director
Purchase at price 366.05 per share.
2026-07-17
1,000 sh
$366,050
BOUDREAUX GAIL A KOZIARA
Chief Executive Officer
Purchase at price 366.41 - 368.25 per share.
2026-07-17
2,725 sh
$1,002,230
PENCZEK RONALD W
Officer
Sale at price 403.16 per share.
2026-06-12
369 sh
$148,766
DIXON ROBERT L JR
Director
Sale at price 401.77 per share.
2026-06-11
151 sh
$60,667
PENCZEK RONALD W
Officer
Sale at price 403.13 per share.
2026-05-19
1,531 sh
$617,192
PENCZEK RONALD W
Officer
Conversion of Exercise of derivative security at price 271.27 - 311.48 per share.
2026-05-19
1,531 sh
$450,579
HAY LEWIS III
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
JALLAL BAHIJA
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
PERU RAMIRO G
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
COLLIS STEVEN HOWARD
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
DIXON ROBERT L JR
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
DEVORE SUSAN D
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
SCHULMAN AMY W.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
STRABLE-SOETHOUT DEANNA D
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
NERI ANTONIO F
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
SCHNEIDER RYAN M.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-13
563 sh
—
SCHULMAN AMY W.
Director
Sale at price 287.50 per share.
2026-03-12
26 sh
$7,475
KENDRICK CHARLES MORGAN JR
Officer
Sale at price 284.92 per share.
2026-03-06
3,196 sh
$910,604
COLLIS STEVEN HOWARD
Director
Purchase at price 289.84 per share.
2026-03-05
3,000 sh
$869,520
KENDRICK CHARLES MORGAN JR
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02
6,549 sh
—
CRAIG RYAN R
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02
2,976 sh
—
WESSLING ERIN M
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02
2,976 sh
—
LAVU RATNAKAR
Chief Technology Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02
11,903 sh
—
NORWOOD FELICIA F.
Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02
8,816 sh
—
KAYE MARK
Chief Financial Officer
Stock Award(Grant) at price 0.00 per share.
2026-03-02
16,579 sh
—